Sernova Biotherapeutics

Sernova Corp. is a health sciences company focused on the development and commercialization of medical technologies in the United States and Canada. Its proprietary platform technologies include the Cell Pouch System, a device that provides a natural organ-like environment for therapeutic cells, such as insulin-producing islets for diabetic patients, and Sertolin, a cell-based technology that creates an immune-privileged environment for donor cells, reducing or eliminating the need for anti-rejection drugs. The company is also working to commercialize products for treating Parkinson’s disease, spinal cord injuries, and hemophilia. Sernova Corp. is headquartered in London, Canada.